Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (261-270 of 286) with videos related to

Pageof 29
Sort By:
The New England Journal of Medicine|February 22, 2018
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee ArthroplastyDavid R Anderson, Michael Dunbar, John Murnaghan, et al.
The New England Journal of Medicine|August 31, 2016
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Truman J Milling, John W Eikelboom, et al.
Journal of Thrombosis and Thrombolysis|March 20, 2012
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, BrazilRenato D Lopes, Richard C Becker, L Kristin Newby, et al.
JAMA|May 20, 2019
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical TrialJean-Louis Vincent, Bruno Francois, Igor Zabolotskikh, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 27, 2021
Ketamine administration for acute painful sickle cell crisis: A randomized controlled trialMohammed S Alshahrani, Amal H AlSulaibikh, Mohamed R ElTahan, et al.
British Journal of Haematology|September 12, 2025
'Raise the Bar', a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementationGrace H Tang, Zoe Phillips, Susan Poutanen, et al.
Journal of Clinical Epidemiology|February 15, 2020
GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tablesHolger J Schünemann, Reem A Mustafa, Jan Brozek, et al.
CMAJ Open|September 26, 2017
Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort studyPavel S Roshanov, John W Eikelboom, Mark Crowther, et al.
Critical Care Medicine|August 28, 2013
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulationJean-Louis Vincent, Mayakonda K Ramesh, David Ernest, et al.
Journal of Clinical Epidemiology|February 16, 2020
GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracyHolger J Schünemann, Reem A Mustafa, Jan Brozek, et al.
Pageof 29

Showing results (261-270 of 286) with videos related to

Sort By:
Pageof 29
The New England Journal of Medicine|February 22, 2018
Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee ArthroplastyDavid R Anderson, Michael Dunbar, John Murnaghan, et al.
The New England Journal of Medicine|August 31, 2016
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Truman J Milling, John W Eikelboom, et al.
Journal of Thrombosis and Thrombolysis|March 20, 2012
Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, BrazilRenato D Lopes, Richard C Becker, L Kristin Newby, et al.
JAMA|May 20, 2019
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical TrialJean-Louis Vincent, Bruno Francois, Igor Zabolotskikh, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|August 27, 2021
Ketamine administration for acute painful sickle cell crisis: A randomized controlled trialMohammed S Alshahrani, Amal H AlSulaibikh, Mohamed R ElTahan, et al.
British Journal of Haematology|September 12, 2025
'Raise the Bar', a Canadian intervention to combat disparities in the recognition and management of iron deficiency: Development of the intervention, feasibility and implementationGrace H Tang, Zoe Phillips, Susan Poutanen, et al.
Journal of Clinical Epidemiology|February 15, 2020
GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tablesHolger J Schünemann, Reem A Mustafa, Jan Brozek, et al.
CMAJ Open|September 26, 2017
Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort studyPavel S Roshanov, John W Eikelboom, Mark Crowther, et al.
Critical Care Medicine|August 28, 2013
A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulationJean-Louis Vincent, Mayakonda K Ramesh, David Ernest, et al.
Journal of Clinical Epidemiology|February 16, 2020
GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracyHolger J Schünemann, Reem A Mustafa, Jan Brozek, et al.
Pageof 29